Evidence map›Paper›PMID 42101565›Full record

ArticleScience China. Life sciences2026

TcrDesign: de novo design of epitope-specific full-length T cell receptors.

Kaixuan Diao, Jing Chen, Xiangyu Zhao, Tao Wu, Die Qiu, Weiliang Wang, Haopeng Wang, Xue-Song Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kaixuan Diao *School of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Jing Chen *School of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Xiangyu ZhaoSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Tao WuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Die QiuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Weiliang WangDepartment of Dermatology, Yangjiang People's Hospital Affiliated to Guangdong Medical University, Yangjiang, 529000, China.
Haopeng WangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China.
Xue-Song LiuSchool of Life Science and Technology, ShanghaiTech University, Shanghai, 201203, China. liuxs@shanghaitech.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cell receptors (TCRs) are essential for adaptive immune recognition. Recently, computational tools have been developed to predict the interactions between TCR and epitope, and artificial intelligence models have been proposed to generate the complementarity determining region 3 (CDR3) region of β chain TCR. However, de novo design of experimentally validated, functional, full-length epitope-specific TCRs remains a significant challenge. Here, we developed TcrDesign, a deep learning framework based on large-scale, unlabeled TCR and epitope datasets to generate epitope-specific, full-length TCRs. TcrDesign comprises two modules: TcrDesign-B for TCR-pMHC binding prediction with state-of-the-art accuracy, and TcrDesign-G for functional full-length TCR sequence generation. Pre-trained on large-scale unlabeled datasets using transformer-based architectures, TcrDesign achieves state-of-the-art performance in both TCR-epitope binding prediction and de novo TCR sequence generation. Furthermore, epitope-major histocompatibility complex (MHC) binding and functional activation of TcrDesign-generated TCRs were experimentally validated. TcrDesign provides an efficient and modular approach for designing epitopespecific full-length TCRs, with experimental validation confirming its utility.

Indexed as

Epitopes, T-LymphocyteImmunoinformaticsReceptors, Antigen, T-CellComplementarity Determining RegionsDeep LearningHumansMajor Histocompatibility ComplexProtein BindingComplementarity Determining RegionsEpitopes, T-LymphocyteReceptors, Antigen, T-Celldeep learningimmunologyTCR designtransformer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.